UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization

Scientific reports, 2022-02, Vol.12 (1), p.3330-3330, Article 3330

2022

Link zum Volltext

Verfügbarkeit prüfen

Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model

Kidney international, 2020-06, Vol.97 (6), p.1196-1207

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors

Nephrology, dialysis, transplantation, 2015-07, Vol.30 (7), p.1185-1192

2015

Link zum Volltext

Verfügbarkeit prüfen

Label Free Detection of Sensitive Mid-Infrared Biomarkers of Glomerulonephritis in Urine Using Fourier Transform Infrared Spectroscopy

Scientific reports, 2017-07, Vol.7 (1), p.4601-12, Article 4601

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

Ophthalmology (Rochester, Minn.), 2015-06, Vol.122 (6), p.1262-1268

2015

Link zum Volltext

Verfügbarkeit prüfen

SYK inhibition in experimental autoimmune vasculitis and its glomerular expression in ANCA-associated vasculitis

The Lancet (British edition), 2014-02, Vol.383, p.S72-S72

2014

Link zum Volltext

Verfügbarkeit prüfen

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Kidney international, 2017-09, Vol.92 (3), p.693-702

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials. Rituximab for maintenance of remission in AAV

Nature reviews. Nephrology, 2015-03, Vol.11 (3), p.131

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2019-01, Vol.34 (1), p.63-73

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of COVID-19 in an Urban Dialysis Center

Journal of the American Society of Nephrology, 2020-08, Vol.31 (8), p.1815-1823

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of the HoloLens2 Mixed Reality Headset for Protecting Health Care Workers During the COVID-19 Pandemic: Prospective, Observational Evaluation

Journal of medical Internet research, 2020-08, Vol.22 (8), p.e21486-e21486

2020

Link zum Volltext

Verfügbarkeit prüfen

Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis

Kidney international, 2021-12, Vol.100 (6), p.1316-1324

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis

Journal of rheumatology, 2018-05, Vol.45 (5), p.686

2018

Link zum Volltext

Verfügbarkeit prüfen

306. PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (5), p.899-899

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcome and treatment of elderly patients with ANCA-associated vasculitis

Clinical journal of the American Society of Nephrology, 2015-07, Vol.10 (7), p.1128-1135

2015

Link zum Volltext

Verfügbarkeit prüfen

260. LONG TERM OUTCOMES OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS PRESENTING WITH SEVERE RENAL DYSFUNCTION

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease

Ophthalmology (Rochester, Minn.), 2015-06, Vol.122 (6), p.1262

2015

Link zum Volltext

Verfügbarkeit prüfen

Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis

Rheumatology (Oxford, England), 2014-09, Vol.53 (9), p.1693-1703

2014

Link zum Volltext

Verfügbarkeit prüfen

Dr. Kang, et al, reply

Journal of rheumatology, 2019-09, Vol.46 (9), p.1244

2019

Link zum Volltext

Verfügbarkeit prüfen

Dr. Kang, et al reply

Journal of rheumatology, 2019-07, Vol.46 (7), p.866

2019

Link zum Volltext

Verfügbarkeit prüfen

Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN

Journal of the American Society of Nephrology, 2014-10, Vol.25 (10), p.2291-2302

2014

Link zum Volltext

Verfügbarkeit prüfen

The mixed reality medical ward round with the MS HoloLens 2: Innovation in reducing COVID-19 transmission and PPE usage

Future healthcare journal, 2021-03, Vol.8 (1), p.e127-e130

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids

Clinical kidney journal, 2017-04, Vol.10 (2), p.233-239

2017

Link zum Volltext

Verfügbarkeit prüfen

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era

Kidney international reports, 2021-01, Vol.6 (1), p.46-55

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)
Berichte
(2)

Sprache

Englisch
(33)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Science & Technology
(20)
Life Sciences & Biomedicine
(18)
Female
(14)
Male
(14)
Urology & Nephrology
(12)
Adult
(10)
Aged
(10)
Middle Aged
(8)
Vasculitis
(7)
Aged, 80 And Over
(6)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Drug Therapy
(6)
Glomerulonephritis
(6)
Immunosuppressive Agents - Therapeutic Use
(6)
Retrospective Studies
(6)
Adolescent
(5)
Follow-Up Studies
(5)
Antibodies, Antineutrophil Cytoplasmic - Blood
(4)
Autoimmune Diseases
(4)
Covid-19
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization

Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors

Label Free Detection of Sensitive Mid-Infrared Biomarkers of Glomerulonephritis in Urine Using Fourier Transform Infrared Spectroscopy

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

SYK inhibition in experimental autoimmune vasculitis and its glomerular expression in ANCA-associated vasculitis

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Clinical trials. Rituximab for maintenance of remission in AAV

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Epidemiology of COVID-19 in an Urban Dialysis Center

Use of the HoloLens2 Mixed Reality Headset for Protecting Health Care Workers During the COVID-19 Pandemic: Prospective, Observational Evaluation

Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis

Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis

306. PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Outcome and treatment of elderly patients with ANCA-associated vasculitis

260. LONG TERM OUTCOMES OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS PRESENTING WITH SEVERE RENAL DYSFUNCTION

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease

Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis

Dr. Kang, et al, reply

Dr. Kang, et al reply

Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN

The mixed reality medical ward round with the MS HoloLens 2: Innovation in reducing COVID-19 transmission and PPE usage

Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids

Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era

Suchergebnisse filtern